The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GSX, GRPN and CTMX

The Gross Law Firm


The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GSX, GRPN and CTMX

Tuesday, June 2, 2020 11:10 AM

NEW YORK, NY / ACCESSWIRE / June 2, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

GSX Techedu Inc. (NYSE:GSX)

Investors Affected : June 6, 2019 - April 13, 2020

A class action has commenced on behalf of certain shareholders in GSX Techedu Inc . The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/gsx-techedu-inc-loss-submission-form/?id=7075&from=1

Groupon, Inc. (NASDAQ:GRPN)

Investors Affected : November 4, 2019 - February 18, 2020

A class action has commenced on behalf of certain shareholders in Groupon, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing fewer customer engagements in its Goods category; (2) Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/groupon-inc-loss-submission-form/?id=7075&from=1

CytomX Therapeutics, Inc. (NASDAQ:CTMX)

Investors Affected : May 17, 2018 - May 13, 2020

A class action has commenced on behalf of certain shareholders in CytomX Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/cytomx-therapeutics-inc-loss-submission-form/?id=7075&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm


SHARE ARTICLE